Bacterial-fungal interactions in the neonatal gut influence asthma outcomes later in life

Rozlyn Ct Boutin1,2, Charisse Petersen2, Sarah E Woodward1,2

  • 1Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.

Elife
|April 20, 2021
PubMed

Insights

Infant gut yeast overgrowth, specifically *Pichia kudriavzevii*, is linked to increased asthma risk. This fungal dysbiosis can worsen allergic airway disease, highlighting the importance of gut fungi in childhood asthma development.

Area of Science:

  • Microbiome research
  • Immunology
  • Pediatric allergy

Background:

  • Bacterial gut microbiota and short-chain fatty acids (SCFAs) are known protective factors against childhood asthma.
  • The role of the gut fungal microbiota in asthma etiology is not well understood.
  • Previous research linked *Pichia kudriavzevii* overgrowth in infants to higher asthma risk.

Purpose of the Study:

  • To replicate findings on *Pichia kudriavzevii* and asthma risk in a new infant cohort.
  • To investigate a causal link between early-life gut fungal dysbiosis and allergic airway disease (AAD).
  • To explore the impact of *Pichia kudriavzevii* on AAD development and the influence of SCFAs.

Main Methods:

  • Replication study in Canadian infants.
  • Utilized a mouse model to study the causal association between neonatal gut *P. kudriavzevii* overgrowth and AAD.
  • Investigated the effect of SCFAs on *P. kudriavzevii* growth and adherence to gut epithelial cells.

Main Results:

  • Findings on *P. kudriavzevii* overgrowth and increased asthma risk were replicated in Canadian infants.
  • Neonatal gut overgrowth of *P. kudriavzevii* in a mouse model exacerbated type-2 and -17 inflammation in AAD.
  • Short-chain fatty acids were shown to modulate *P. kudriavzevii* growth and its adherence to gut epithelial cells.

Conclusions:

  • Early-life gut fungal dysbiosis, particularly *Pichia kudriavzevii* overgrowth, is causally associated with allergic airway disease.
  • Interactions between gut fungi and host immunity play a significant role in asthma development.
  • Targeting inter-kingdom microbial interactions, specifically fungal components, may offer novel therapeutic strategies for asthma.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
629
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
921
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
561